Transverse Myelitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must have a confirmed pregnancy (either current or past) that qualifies for the study.
- You (or your parent/legal guardian if you are a minor) must be willing and able to sign a consent form before joining.
- You must be willing to share your contact information with the study team.
- You must be willing to allow your doctor(s) to share your medical information and your baby's medical information with the study, where local rules allow.
- You must have a medical condition for which the drug Ultomiris has been officially approved, confirmed by a doctor or medical records.
- You must have been treated with Ultomiris at some point during a specific time window — this includes before conception, during pregnancy, or while breastfeeding (even if exact dates are unknown, an estimate of timing is acceptable).
- Your use of Ultomiris must have followed the official prescribing guidelines in your country.
Who may not be able to join:
- People who are not able to give their own consent or agreement to participate — for example, those with severe psychiatric conditions or severe intellectual disabilities — are not eligible for this study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sydney Williams, North American Coordinating Center (NACC)
Phone: 1-855-752-2356
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Pregnancy Complications; Maternal Complications; Fetal/Infant Outcomes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.